STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES. (2023). International Journal of Pharmaceutical Sciences and Drug Research, 15(6), 764-769. https://doi.org/10.25004/IJPSDR.2023.150610